These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 7981057

  • 41. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH, Barlowe CK, Goldman ID.
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [Abstract] [Full Text] [Related]

  • 42. Design and rationale for novel antifolates.
    Bertino JR, Sobrero A, Mini E, Moroson BA, Cashmore A.
    NCI Monogr; 1987 Feb; (5):87-91. PubMed ID: 3431593
    [Abstract] [Full Text] [Related]

  • 43. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
    Diddens H, Niethammer D, Jackson RC.
    Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
    [Abstract] [Full Text] [Related]

  • 44. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.
    McGinn CJ, Pestalozzi BC, Drake JC, Glennon MC, Kunugi K, Otterson G, Allegra CJ, Johnston PG, Kinsella TJ.
    Cancer J; 2000 Nov; 6(4):234-42. PubMed ID: 11038143
    [Abstract] [Full Text] [Related]

  • 45. In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells.
    Guglielmi A, Aschele C, Mori A, Baldo C, Russo P, Debernardis D, Valenti M, Bruno S, Taverna M, Rosso R.
    Clin Cancer Res; 1995 Nov; 1(11):1337-44. PubMed ID: 9815929
    [Abstract] [Full Text] [Related]

  • 46. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
    van Triest B, Pinedo HM, van Hensbergen Y, Smid K, Telleman F, Schoenmakers PS, van der Wilt CL, van Laar JA, Noordhuis P, Jansen G, Peters GJ.
    Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
    [Abstract] [Full Text] [Related]

  • 47. p14ARF expression increases dihydrofolate reductase degradation and paradoxically results in resistance to folate antagonists in cells with nonfunctional p53.
    Magro PG, Russo AJ, Li WW, Banerjee D, Bertino JR.
    Cancer Res; 2004 Jun 15; 64(12):4338-45. PubMed ID: 15205349
    [Abstract] [Full Text] [Related]

  • 48. Inherent resistance of human squamous carcinoma cell lines to methotrexate as a result of decreased polyglutamylation of this drug.
    Pizzorno G, Chang YM, McGuire JJ, Bertino JR.
    Cancer Res; 1989 Oct 01; 49(19):5275-80. PubMed ID: 2475246
    [Abstract] [Full Text] [Related]

  • 49. Specificity of ribozyme designed for mutated DHFR mRNA.
    Kobayashi H, Kim N, Halatsch ME, Ohnuma T.
    Biochem Pharmacol; 1994 Apr 29; 47(9):1607-13. PubMed ID: 8185675
    [Abstract] [Full Text] [Related]

  • 50. Synergistic growth inhibition of rat hepatoma cells exposed in vitro to N10-propargyl-5,8-dideazafolate with methotrexate or the lipophilic antifolates trimetrexate or metoprine.
    Galivan J, Nimec Z, Rhee M.
    Cancer Res; 1987 Oct 15; 47(20):5256-60. PubMed ID: 2958130
    [Abstract] [Full Text] [Related]

  • 51. Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate.
    Curt GA, Jolivet J, Carney DN, Bailey BD, Drake JC, Clendeninn NJ, Chabner BA.
    J Clin Invest; 1985 Oct 15; 76(4):1323-9. PubMed ID: 2414316
    [Abstract] [Full Text] [Related]

  • 52. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.
    Dempke WC, Shellard SA, Hosking LK, Fichtinger-Schepman AM, Hill BT.
    Carcinogenesis; 1992 Jul 15; 13(7):1209-15. PubMed ID: 1638688
    [Abstract] [Full Text] [Related]

  • 53. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways.
    Hardy LW, Matthews W, Nare B, Beverley SM.
    Exp Parasitol; 1997 Nov 15; 87(3):157-69. PubMed ID: 9371081
    [Abstract] [Full Text] [Related]

  • 54. Cytotoxic effects of folate antagonists against methotrexate-resistant human leukemic lymphoblast CCRF-CEM cell lines.
    Mini E, Moroson BA, Franco CT, Bertino JR.
    Cancer Res; 1985 Jan 15; 45(1):325-30. PubMed ID: 3855284
    [Abstract] [Full Text] [Related]

  • 55. Development of an assay system for the detection and classification of methotrexate resistance in fresh human leukemic cells.
    Rodenhuis S, McGuire JJ, Narayanan R, Bertino JR.
    Cancer Res; 1986 Dec 15; 46(12 Pt 1):6513-9. PubMed ID: 2946404
    [Abstract] [Full Text] [Related]

  • 56. Antifolate resistance and its circumvention by new analogues.
    Takemura Y, Kobayashi H, Miyachi H.
    Hum Cell; 2001 Sep 15; 14(3):185-202. PubMed ID: 11774738
    [Abstract] [Full Text] [Related]

  • 57. Effect of combined inhibitors of thymidylate synthase-5-fluorodeoxyuridine and quinazoline antifolates on murine leukemia cells cultured in vitro.
    Balinska M, Szablewska I, Janiszewska D, Brzezinska A, Pawelczak K.
    Anticancer Res; 1997 Sep 15; 17(6D):4519-24. PubMed ID: 9494561
    [Abstract] [Full Text] [Related]

  • 58. Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: the association with treatment efficacy of pemetrexed.
    Chen CY, Chang YL, Shih JY, Lin JW, Chen KY, Yang CH, Yu CJ, Yang PC.
    Lung Cancer; 2011 Oct 15; 74(1):132-8. PubMed ID: 21367480
    [Abstract] [Full Text] [Related]

  • 59. Quartz crystal microbalance with dissipation and microscale thermophoresis as tools for investigation of protein complex formation between thymidylate synthesis cycle enzymes.
    Antosiewicz A, Senkara E, Cieśla J.
    Biosens Bioelectron; 2015 Feb 15; 64():36-42. PubMed ID: 25189098
    [Abstract] [Full Text] [Related]

  • 60. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
    Sakoff JA, Howitt IJ, Ackland SP, McCluskey A.
    Cancer Chemother Pharmacol; 2004 Mar 15; 53(3):225-32. PubMed ID: 14648018
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.